If this is correct --- the glycine leaching results will be released later than originally announced as it will be combined with the Scoping Study that has been extended to align with the Strategic Review,----
then the delay is understandable.
I am assuming that's what is happening but don't know for certain.
- Forums
- ASX - By Stock
- EM2
- EM2
EM2, page-229
Featured News
Add EM2 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.001(2.38%) |
Mkt cap ! $16.10M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.1¢ | $38.05K | 922.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 137500 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 61072 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 137500 | 0.040 |
1 | 61000 | 0.039 |
2 | 90000 | 0.038 |
1 | 12000 | 0.037 |
2 | 24300 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 61072 | 1 |
0.042 | 257340 | 1 |
0.043 | 108535 | 1 |
0.044 | 76825 | 1 |
0.045 | 20001 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EM2 (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online